Principal Investigator
Gilberto Lopes
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230559
Clinical Trial Summary
A Phase 1/2 Open-label, Multicenter Study to Assess the
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics,
and Efficacy of PC14586 in Patients with Locally Advanced or
Metastatic Solid Tumors Harboring a TP53 Y220C Mutation
(PYNNACLE)
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Thoracic Oncology
Contact Information
Phone Number
305-243-2647